Deliver a professional meningococcal b protection service through Scripter's structured consultation pathway. Supply: Meningococcal group B vaccine (Bexsero), course per age.
The MenB vaccine is a non-live vaccine offered privately to children who missed the infant programme and to adolescents and young adults heading to university, where group B disease clusters. The number of doses depends on age at the first dose.
Meningococcal group B bacteria cause meningitis and septicaemia that can kill within hours or leave lasting disability. Teenagers and young adults carry the bacteria at the highest rates, which is why vaccination before university is common.
Patients book online, complete the pre-consultation questionnaire, and the guided pathway walks the practitioner through the meningococcal b protection consultation with the screening and counselling steps built in. The supply decision, the record and any GP notification are produced in the same flow, documented against the exact protocol version in force.
Who can deliver this service, and who it can be delivered to. The governing PGD document defines the definitive inclusion, exclusion and supply criteria; the Scripter consultation pathway enforces them, and every consultation is documented against the protocol version it ran under.
Related protocols in the same category, all delivered through the same platform.
Chickenpox prevention
View PGDShingles prevention
View PGDHPV-related cancer prevention
View PGDMeasles, mumps and rubella protection
View PGDRSV protection in older adults
View PGDOccupational hepatitis B protection
View PGDSee the consultation pathway, the sign-off tracking and the record it produces in a free 30-minute demo.